Radiosurgery for Chordoma and Chondrosarcoma.

Area of Science:

• Oncology
• Neurosurgery
• Radiation Oncology

Background:

• Chordomas and chondrosarcomas are rare, locally aggressive skull base tumors.
• These tumors have high rates of progression and recurrence.
• Effective management often requires multimodality treatment, including surgery, radiation therapy, and stereotactic radiosurgery (SRS).

Purpose of the Study:

• To examine the role and efficacy of stereotactic radiosurgery (SRS) in managing skull base chordomas and chondrosarcomas.
• To review SRS as a treatment option for patients with recurrent or residual tumors.

Main Methods:

• Review of existing literature and clinical data on SRS for skull base chordomas and chondrosarcomas.
• Analysis of treatment outcomes, including progression-free survival and local control rates.
• Evaluation of SRS in the context of multimodality treatment protocols.

Main Results:

• Stereotactic radiosurgery (SRS) is a recognized management option for skull base chordomas and chondrosarcomas.
• SRS is particularly utilized for recurrent or residual tumors following initial surgical resection and fractionated radiation therapy.
• The effectiveness of SRS in controlling tumor progression and recurrence is a key focus.

Conclusions:

• Stereotactic radiosurgery (SRS) plays a significant role in the multimodality management of skull base chordomas and chondrosarcomas.
• SRS offers a valuable therapeutic option for patients with challenging recurrent or residual disease.
• Further investigation into optimal SRS protocols may enhance outcomes for these rare tumors.